Applications of metabolomics in cancer research
暂无分享,去创建一个
[1] E. Mikros,et al. (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool. , 2010, Journal of proteome research.
[2] Royston Goodacre,et al. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. , 2011, Chemical Society reviews.
[3] P. West,et al. Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. , 2010, Toxicology and applied pharmacology.
[4] Eyal Gottlieb,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[5] Daniel Raftery,et al. Early detection of recurrent breast cancer using metabolite profiling. , 2010, Cancer research.
[6] Ivano Bertini,et al. Evidence of different metabolic phenotypes in humans , 2008, Proceedings of the National Academy of Sciences.
[7] A. Alavi,et al. Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.
[8] R. Weiss,et al. Urinary acylcarnitines are altered in human kidney cancer , 2012, International Journal of Cancer.
[9] G. Semenza,et al. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.
[10] S. Choi,et al. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis. , 2012, Cancer research.
[11] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[12] Yuen-Li Chung,et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. , 2005, Cancer cell.
[13] M. Arbushites,et al. Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: A pilot study , 2012, Molecular oncology.
[14] John C Lindon,et al. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism , 2009, Proceedings of the National Academy of Sciences.
[15] Pär Stattin,et al. Metabolomic Characterization of Human Prostate Cancer Bone Metastases Reveals Increased Levels of Cholesterol , 2010, PloS one.
[16] Shih-Chieh Lin,et al. Induction of Pyruvate Dehydrogenase Kinase-3 by Hypoxia-inducible Factor-1 Promotes Metabolic Switch and Drug Resistance* , 2008, Journal of Biological Chemistry.
[17] F. Ducray,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[18] Chi V Dang,et al. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. , 2010, Cancer research.
[19] Jin-lian Chen,et al. Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS. , 2011, World journal of gastroenterology.
[20] Yusuke Nakamura,et al. Merging pharmacometabolomics with pharmacogenomics using ‘1000 Genomes’ single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics , 2012, Pharmacogenetics and genomics.
[21] J R Griffiths,et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.
[22] Oliver Fiehn,et al. Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry , 2007, BMC Bioinformatics.
[23] J. Lindon,et al. Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.
[24] Yiran Huang,et al. Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis. , 2008, Analytica chimica acta.
[25] John C Lindon,et al. Pharmacometabonomics as an effector for personalized medicine. , 2011, Pharmacogenomics.
[26] G. Kristiansen,et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. , 2010, European urology.
[27] A. Cebrián,et al. Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics , 2011, Clinical and Translational Oncology.
[28] Oliver Fiehn,et al. A comprehensive urinary metabolomic approach for identifying kidney cancerr. , 2007, Analytical biochemistry.
[29] L. Liau,et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.
[30] W. Dunn,et al. Measuring the metabolome: current analytical technologies. , 2005, The Analyst.
[31] Yong Yue,et al. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. , 2007, Journal of proteome research.
[32] A. Darzi,et al. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication. , 2013, Journal of proteome research.
[33] P. Ward,et al. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.
[34] Elaine Holmes,et al. High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues , 2010, Nature Protocols.
[35] Tsung-Cheng Chang,et al. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.
[36] E. Fukusaki,et al. Serum metabolomics as a novel diagnostic approach for pancreatic cancer , 2010, Metabolomics.
[37] O. Slanař,et al. Human urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation. , 2009, Journal of proteome research.
[38] Alan Hutson,et al. Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics , 2005, International journal of cancer.
[39] Jason W. Locasale,et al. Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells , 2010, Science.
[40] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[41] David S. Wishart,et al. HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..
[42] Thomas M O'Connell,et al. Recent advances in metabolomics in oncology. , 2012, Bioanalysis.
[43] Chi V. Dang,et al. The interplay between MYC and HIF in cancer , 2008, Nature Reviews Cancer.
[44] Ru Wei,et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.
[45] Tao-Tao Liu,et al. A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.
[46] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[47] H. Thomas,et al. Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study. , 2011, Journal of proteome research.
[48] Edoardo Saccenti,et al. Individual human phenotypes in metabolic space and time. , 2009, Journal of proteome research.
[49] Z. Bhujwalla,et al. Molecular Causes of the Aberrant Choline Phospholipid Metabolism in Breast Cancer , 2004, Cancer Research.
[50] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[51] Shuying Liu,et al. A METABONOMICS STUDY OF COLORECTAL CANCER BY RRLC-QTOF/MS , 2012 .
[52] Tianlu Chen,et al. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. , 2009, Journal of proteome research.
[53] O. Fiehn,et al. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. , 2006, Cancer research.
[54] Ping Liu,et al. Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma* , 2011, Molecular & Cellular Proteomics.
[55] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[56] Xiaomei Yan,et al. Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer. , 2010, The Analyst.
[57] O. Fiehn. Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.
[58] Xiaomei Yan,et al. LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery. , 2011, Journal of proteome research.
[59] Daniel K Nomura,et al. Global profiling strategies for mapping dysregulated metabolic pathways in cancer. , 2012, Cell metabolism.
[60] Qing Yang,et al. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[61] Alexander G. Gray,et al. Rapid Mass Spectrometric Metabolic Profiling of Blood Sera Detects Ovarian Cancer with High Accuracy , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[62] Reinhard Laubenbacher,et al. Bioinformatics tools for cancer metabolomics , 2011, Metabolomics.
[63] Liping Zhao,et al. Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats. , 2007, Journal of proteome research.
[64] Hui Sun,et al. Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[65] L. Tenori,et al. Targeting Metabolomics in Breast Cancer , 2012, Current Breast Cancer Reports.
[66] Oksana Gavrilova,et al. p53 Regulates Mitochondrial Respiration , 2006, Science.
[67] S. Clarke,et al. Pharmacometabonomic Profiling as a Predictor of Toxicity in Patients with Inoperable Colorectal Cancer Treated with Capecitabine , 2011, Clinical Cancer Research.
[68] Claudio Luchinat,et al. Uncovering the metabolomic fingerprint of breast cancer. , 2011, The international journal of biochemistry & cell biology.
[69] R. Deberardinis,et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.
[70] T. Takenawa,et al. A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer , 2012, PloS one.
[71] Xin Lu,et al. Metabolomic Changes Accompanying Transformation and Acquisition of Metastatic Potential in a Syngeneic Mouse Mammary Tumor Model* , 2010, The Journal of Biological Chemistry.
[72] Timothy M. D. Ebbels,et al. Consensus-Phenotype Integration of Transcriptomic and Metabolomic Data Implies a Role for Metabolism in the Chemosensitivity of Tumour Cells , 2011, PLoS Comput. Biol..
[73] Yiran Huang,et al. Application of ex vivo 1H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases , 2012, Journal of Cancer Research and Clinical Oncology.
[74] Z. Bhujwalla,et al. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. , 1999, Cancer research.
[75] Hui Cong,et al. Application of 1H NMR‐based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis , 2009, Cancer science.
[76] G. Semenza. HIF-1: upstream and downstream of cancer metabolism. , 2010, Current opinion in genetics & development.
[77] Bowei Xi,et al. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer. , 2011, Analytica chimica acta.
[78] David Beach,et al. Glycolytic enzymes can modulate cellular life span. , 2005, Cancer research.
[79] W. Kaelin. Faculty Opinions recommendation of Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. , 2008 .
[80] K. Kinzler,et al. Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome , 2011, Proceedings of the National Academy of Sciences.
[81] A. M. Gil,et al. Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids. , 2012, Progress in nuclear magnetic resonance spectroscopy.
[82] Xi-jun Wang,et al. Modern analytical techniques in metabolomics analysis. , 2012, The Analyst.
[83] Frank M. Sacks,et al. IDH 1 and IDH 2 Mutations in Gliomas , 2009 .
[84] R. Weiss,et al. Urine metabolomics for kidney cancer detection and biomarker discovery. , 2011, Urologic oncology.
[85] R. Deberardinis,et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. , 2012, Cell metabolism.
[86] Tao Zhang,et al. Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling. , 2013, Journal of proteome research.
[87] E. Gottlieb,et al. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.
[88] Flavio Rizzolio,et al. Pharmaco‐metabolomics: An emerging “omics” tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets , 2012, Journal of cellular physiology.
[89] Joachim Selbig,et al. Metabolic profiling reveals key metabolic features of renal cell carcinoma , 2009, Journal of cellular and molecular medicine.
[90] O. Fiehn,et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. , 2009, Analytical chemistry.
[91] R. Weiss,et al. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. , 2011, Omics : a journal of integrative biology.
[92] John Kurhanewicz,et al. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. , 2011, Neoplasia.
[93] A. Mancuso,et al. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase , 2011, Nature Cell Biology.
[94] H. Degani,et al. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. , 2002, Cancer research.
[95] Tianlu Chen,et al. Urinary metabonomic study on colorectal cancer. , 2010, Journal of proteome research.
[96] Kyoungmi Kim,et al. Urine Metabolomics Analysis for Kidney Cancer Detection and Biomarker Discovery*S , 2009, Molecular & Cellular Proteomics.
[97] Rachel Cavill,et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). , 2009, Journal of proteome research.
[98] Ivano Bertini,et al. Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. , 2012, Cancer research.
[99] Theodoros N. Arvanitis,et al. Birmingham Metabolite Library: a publicly accessible database of 1-D 1H and 2-D 1H J-resolved NMR spectra of authentic metabolite standards (BML-NMR) , 2011, Metabolomics.
[100] P. Morris,et al. Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[101] Eyal Gottlieb,et al. TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.
[102] Joachim Selbig,et al. The Golm Metabolome Database: a database for GC-MS based metabolite profiling , 2007 .
[103] V. Mootha,et al. Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation , 2012, Science.
[104] S. Orsulic,et al. Ovarian Cancer , 1993, British Journal of Cancer.
[105] N. Denko,et al. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.
[106] John T. Wei,et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.
[107] T. Sørlie,et al. Merging transcriptomics and metabolomics - advances in breast cancer profiling , 2010, BMC Cancer.
[108] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[109] J. Dufour,et al. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. , 2011, Cancer research.
[110] W. Moon,et al. An HR-MAS MR Metabolomics Study on Breast Tissues Obtained with Core Needle Biopsy , 2011, PloS one.
[111] M. Sawyer,et al. Urine Metabolite Analysis Offers Potential Early Diagnosis of Ovarian and Breast Cancers , 2010, Clinical Cancer Research.
[112] E. Negelein,et al. THE METABOLISM OF CARCINOMA CELLS , 2011 .